Log in to Congenica
Please select your location and reference genome:

Latest News and Blogs

Institute of Immunology and Genetics in Kaiserslautern selects Congenica to accelerate its whole exome sequencing

Institute of Immunology and Genetics in Kaiserslautern selects Congenica to accelerate its whole exome sequencing

Congenica announces a new contract with the Institute of Immunology and Genetics, a leading molecular genetic laboratory in Kaiserslautern, Germany

Why my five-year-old daughter is my inspiration as we fight to understand her sister’s epilepsy

Why my five-year-old daughter is my inspiration as we fight to understand her sister’s epilepsy

March 26 is #Purpleday, an international awareness day that aims to get people talking about epilepsy and raise awareness of the condition. Congenica welcomes guest blogger Adam Clatworthy to tell ...

Sanford Health partners with Congenica to provide answers for undiagnosed rare disease patients

Sanford Health partners with Congenica to provide answers for undiagnosed rare disease patients

Sanford Health selects Congenica clinical decision support platform and NGS data analysis software to provide answers for undiagnosed rare disease patients

Congenica signs distribution agreement with AmpliTech in France

Congenica signs distribution agreement with AmpliTech in France

Congenica, the digital health company enabling rapid and accurate analysis of genomic data, announces a distribution agreement with AmpliTech.   

Congenica Appoints Kamraan Shariff as Chief Business Development Officer

Congenica Appoints Kamraan Shariff as Chief Business Development Officer

Congenica, the company enabling rapid and accurate NGS data analysis to transform lives, today announces the appointment of Kamraan Shariff.

Rare Disease Day 2021 - Live Blog

Rare Disease Day 2021 - Live Blog

The main objective of Rare Disease Day is to raise awareness amongst the public & decision-makers about rare diseases and their impact on patients' lives.

Achieving the highest diagnostic yield possible with phenotype-based prioritization of variants

Achieving the highest diagnostic yield possible with phenotype-based prioritization of variants

Genomic sequencing has the potential to rapidly analyze critically ill babies and children and also to predict a response to infectious diseases and potential therapeutic compounds.

Why a diagnosis is so important for rare disease patients

Why a diagnosis is so important for rare disease patients

Maybe you are an aunt or uncle of a child or may have friends who have children. Whatever the relationship you have, children are life-changing.

David Atkins joins the National Genomics Board as BIA SME representative

David Atkins joins the National Genomics Board as BIA SME representative

David Atkins, CEO of NGS data analysis software company Congenica, has joined the National Genomics Board to advise on the UK national genomics strategy.

Congenica Enters Cancer Collaboration with University of Glasgow Spinout Gabriel Precision Oncology

Congenica Enters Cancer Collaboration with University of Glasgow Spinout Gabriel Precision Oncology

Congenica and Gabriel will develop a highly automated somatic cancer clinical interpretation software platform.

Webinar on Demand: Enabling Genomic Medicine

Webinar on Demand: Enabling Genomic Medicine

Genomic medicine has opened the possibility to transform the health and wellness of individuals around the world with life-changing diagnoses and treatments that would never have been previously ...

Congenica Contributes to Key Priority within UK Rare Disease Framework

Congenica Contributes to Key Priority within UK Rare Disease Framework

The UK’s Department of Health has published its UK Rare Disease Framework, setting out the key priorities for the rare disease community.